{"title":"Brain Metastasis From Angiosarcoma of the Scalp: Report of Three Cases","authors":"Mami Kudo, Riku Shirato, Teruki Yanagi, Wataru Yamagata, Akira Yogi, Aoi Ohira, Ririko Iwamoto, Kenzo Takahashi","doi":"10.1111/1346-8138.17858","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Brain metastasis from cutaneous angiosarcoma of the scalp is rare, and the characteristics and optimal treatment remain poorly understood. Herein, we report three cases of brain metastasis originating from cAS of the scalp. Case 1: An 81-year-old male developed lung metastasis 2.5 years after initial diagnosis, followed by brain metastasis 1 year later. He passed away 1 month after the detection of brain metastasis. Case 2: A 66-year-old male presented with lung and cervical lymph node metastases at the time of initial diagnosis. Brain metastasis was identified 5 months later after the onset of dizziness, and he passed away 2 months thereafter. Case 3: A 68-year-old male developed lung metastasis 7 months after initial diagnosis. Brain metastasis was detected 1 month later via computed tomography (CT). Palliative radiation therapy (30 Gy) led to a reduction in the size of the metastatic brain lesion; however, he passed away 2 months later. In each case, plain CT scans showed multiple high-density areas. The period from brain metastasis detection to death was uniformly short, within 2 months. These findings suggest that brain metastasis in cutaneous angiosarcoma of the scalp is associated with a poor prognosis.</p>\n </div>","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"52 9","pages":"1456-1460"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dermatology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.17858","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Brain metastasis from cutaneous angiosarcoma of the scalp is rare, and the characteristics and optimal treatment remain poorly understood. Herein, we report three cases of brain metastasis originating from cAS of the scalp. Case 1: An 81-year-old male developed lung metastasis 2.5 years after initial diagnosis, followed by brain metastasis 1 year later. He passed away 1 month after the detection of brain metastasis. Case 2: A 66-year-old male presented with lung and cervical lymph node metastases at the time of initial diagnosis. Brain metastasis was identified 5 months later after the onset of dizziness, and he passed away 2 months thereafter. Case 3: A 68-year-old male developed lung metastasis 7 months after initial diagnosis. Brain metastasis was detected 1 month later via computed tomography (CT). Palliative radiation therapy (30 Gy) led to a reduction in the size of the metastatic brain lesion; however, he passed away 2 months later. In each case, plain CT scans showed multiple high-density areas. The period from brain metastasis detection to death was uniformly short, within 2 months. These findings suggest that brain metastasis in cutaneous angiosarcoma of the scalp is associated with a poor prognosis.
期刊介绍:
The Journal of Dermatology is the official peer-reviewed publication of the Japanese Dermatological Association and the Asian Dermatological Association. The journal aims to provide a forum for the exchange of information about new and significant research in dermatology and to promote the discipline of dermatology in Japan and throughout the world. Research articles are supplemented by reviews, theoretical articles, special features, commentaries, book reviews and proceedings of workshops and conferences.
Preliminary or short reports and letters to the editor of two printed pages or less will be published as soon as possible. Papers in all fields of dermatology will be considered.